Literature DB >> 10325699

Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study.

A Schlieper1, E Orrbine, G A Wells, M Clulow, P N McLaine, P C Rowe.   

Abstract

BACKGROUND: Severe haemolytic uraemic syndrome (HUS) in childhood can cause stroke, hemiplegia, cortical blindness, and psychomotor retardation. These outcomes are evident at the time of discharge immediately after the acute illness. Less is known about the neuropsychological outcomes of less severely affected children who recover from acute HUS. AIMS: This multicentre case control study investigated the hypothesis that children who survive an acute episode of HUS without recognizable neurological injuries have greater impairment of cognitive, academic, and behavioural functions than controls.
DESIGN: Children with HUS were eligible if they had no evidence of severe neurological dysfunction when discharged from one of six Canadian hospitals. Controls had been admitted to hospital for a non-HUS illness and were matched by age, sex, first language, and socioeconomic status. All subjects underwent evaluation of behaviour, academic achievement, cognitive function, and verbal abilities using standardised tests administered by a psychometrist blinded to the case or control status.
RESULTS: Ninety-one case control pairs were enrolled. No important differences between patients with HUS and paired controls were evident on tests of IQ, behaviour, verbal abilities, or academic achievement. There was no increased risk of attention deficit disorder among patients with HUS. There was no correlation between the severity of acute renal failure and neuropsychological measures, although scores on some verbal ability tests were lower in those with the highest serum creatinine concentrations during illness.
CONCLUSIONS: Children discharged from hospital without apparent neurological injury after an episode of acute HUS do not have an increased risk of subclinical problems with learning, behaviour, or attention.

Entities:  

Mesh:

Year:  1999        PMID: 10325699      PMCID: PMC1717871          DOI: 10.1136/adc.80.3.214

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  21 in total

1.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

2.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

3.  Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center.

Authors:  P C Rowe; E Orrbine; H Lior; G A Wells; E Yetisir; M Clulow; P N McLaine
Journal:  J Pediatr       Date:  1998-05       Impact factor: 4.406

4.  The hemolytic-uremic syndrome.

Authors:  C A Gianantonio; M Vitacco; F Mendilaharzu; G E Gallo; E T Sojo
Journal:  Nephron       Date:  1973       Impact factor: 2.847

5.  An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome.

Authors:  B S Kaplan; J Katz; S Krawitz; A Lurie
Journal:  J Pediatr       Date:  1971-03       Impact factor: 4.406

6.  Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome.

Authors:  J C Rooney; R M Anderson; I J Hopkins
Journal:  Aust Paediatr J       Date:  1971-03

7.  Manual for scoring socioeconomic status for research on health behavior.

Authors:  L W Green
Journal:  Public Health Rep       Date:  1970-09       Impact factor: 2.792

8.  A longitudinal study of the cognitive function of children with renal failure.

Authors:  R S Fennell; E B Fennell; R L Carter; E L Mings; A B Klausner; J R Hurst
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

9.  Long-term neurological sequelae of hemolytic-uremic syndrome: a preliminary report.

Authors:  I U Qamar; M Ohali; D L MacGregor; C Wasson; K Krekewich; S Marcovitch; G S Arbus
Journal:  Pediatr Nephrol       Date:  1996-08       Impact factor: 3.714

10.  Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.

Authors:  P C Rowe; E Orrbine; G A Wells; P N McLaine
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

View more
  14 in total

Review 1.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

2.  Neurodevelopmental long-term outcome in children after hemolytic uremic syndrome.

Authors:  Kathrin Buder; Beatrice Latal; Samuel Nef; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2014-09-19       Impact factor: 3.714

3.  Long-term health-related quality of life and psychological adjustment in children after haemolytic-uraemic syndrome.

Authors:  Helene Werner; Kathrin Buder; Markus A Landolt; Thomas J Neuhaus; Guido F Laube; Giuseppina Spartà
Journal:  Pediatr Nephrol       Date:  2016-12-23       Impact factor: 3.714

Review 4.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

5.  Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS).

Authors:  Myda Khalid; Sharon Andreoli
Journal:  Pediatr Nephrol       Date:  2018-11-01       Impact factor: 3.714

6.  Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome.

Authors:  Angela Bauer; Sebastian Loos; Carola Wehrmann; Dirk Horstmann; Frank Donnerstag; Johanna Lemke; Georg Hillebrand; Ulrike Löbel; Lars Pape; Dieter Haffner; Carola Bindt; Thurid Ahlenstiel; Anette Melk; Anja Lehnhardt; Markus J Kemper; Jun Oh; Hans Hartmann
Journal:  Pediatr Nephrol       Date:  2014-03-25       Impact factor: 3.714

Review 7.  Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.

Authors:  Benoit Travert; Cédric Rafat; Patricia Mariani; Aurélie Cointe; Antoine Dossier; Paul Coppo; Adrien Joseph
Journal:  Toxins (Basel)       Date:  2021-04-26       Impact factor: 4.546

8.  Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement.

Authors:  Lars Pape; Hans Hartmann; Franz Christoph Bange; Sebastian Suerbaum; Eva Bueltmann; Thurid Ahlenstiel-Grunow
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

9.  Neuropsychological outcome after complicated Shiga toxin-producing Escherichia coli infection.

Authors:  Olga Simova; Gabriele Weineck; Thorsten Schuetze; Karl Wegscheider; Ulf Panzer; Rolf A K Stahl; Christian Gerloff; Tim Magnus
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

10.  Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome.

Authors:  Ramona Schuppner; Justus Maehlmann; Meike Dirks; Hans Worthmann; Anita B Tryc; Kajetan Sandorski; Elisabeth Bahlmann; Jan T Kielstein; Anja M Giesemann; Heinrich Lanfermann; Karin Weissenborn
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.